Clinical Trials Browser

NIH × Breast Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Adenocarcinoma, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT00179309 2014-07-15

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Phase 2 Completed

48 enrolled 11 charts

Breast

Breast Neoplasms

NCT00028496 2013-01-25

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

48 enrolled

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Carcinoma, Medullary, Breast Neoplasms, Male

NCT00001239 2008-03-04

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Phase 2 Completed

100 enrolled

Breast

Breast Neoplasms

NCT00001338 2008-03-04

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Phase 3 Completed

65 enrolled

Breast

Breast Neoplasms, Fever, Hematologic Diseases, Neutropenia, Sepsis

Clinical Trials

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer